window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Merck

  • Drug Discovery & Development,Manufacturing & Supply Chain

    Merck launches bio-based HPLC solvents for pharma labs

    Merck has launched a portfolio of bio-based solvents for high-performance [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Quotient and Merck partner on somatic genomics drug targets in inflammatory bowel disease

    Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA accepts Merck NDA for pimicotinib in tenosynovial giant cell tumor

    Merck has announced that the US Food and Drug Administration [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Merck opens climate-neutral €150 million filter manufacturing facility in Ireland

    Merck has inaugurated its first climate-neutral manufacturing facility in Ireland, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Merck halts £1bn London research centre, raising fresh concerns over UK competitiveness

    MSD, known as Merck & Co. in the US, says [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    MSD strengthens commercial capabilities with commitment to Veeva Vault CRM ahead of major launches

    Global pharma leader MSD (Merck outside the US and Canada) [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • RxLogix launches AI pharmacovigilance platform for adverse event monitoring
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development
  • Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top